| The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. | None |
| Drosophila genes Posterior Sex Combs and Suppressor two of zeste encode proteins with homology to the murine bmi-1 oncogene. | None |
| Oncoprotein BMI-1 induces the malignant transformation of HaCaT cells. | None |
| Sequence similarity between the mammalian bmi-1 proto-oncogene and the Drosophila regulatory genes Psc and Su(z)2. | None |
| BMI1 acts as an oncogene and Mel-18 functions as a tumor suppressor via downregulation of BMI1. | None |
| Stem cell divisions controlled by the proto-oncogene BMI-1. | None |
| Deletion analysis of BMI1 oncoprotein identifies its negative regulatory domain. | None |
| BMI1 as a novel target for drug discovery in cancer. | None |
| It has been clearly established that BMI1 is a bonafide oncogene and plays critical roles in promoting cancer stem cell self-renewal and tumorogenesis. | None |
| Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation. | None |
| A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer. | None |
| Data indicate that miR-203 suppressed BMI1 polycomb ring finger oncogene protein (Bmi-1) expression by directly targeting the 3_-untranslated region. | None |
| Characterization and chromosomal localization of the human proto-oncogene BMI-1. | None |
| Transformation by the Bmi-1 oncoprotein correlates with its subnuclear localization but not its transcriptional suppression activity. | None |
| Cloning of the rat proto-oncogene bmi-1. | None |